We found that VILIP3 alleviated cognitive deficits in AD mice, highlighting its clinical relevance as progressive cognitive decline is a core AD symptom and major contributor to daily functional decline (Scheltens et al. 2021). This evidence concerns the gene HPCAL1 and Mental deterioration.